VEA
Virtus ETF Advisers Portfolio holdings
AUM
$75.7M
This Quarter Return
+23.55%
1 Year Return
+23.01%
3 Year Return
+79.79%
5 Year Return
+153.94%
10 Year Return
–
AUM
$135M
AUM Growth
+$135M
(+86%)
Cap. Flow
+$51.4M
Cap. Flow
% of AUM
38.13%
Top 10 Holdings %
Top 10 Hldgs %
44.79%
Holding
161
New
7
Increased
113
Reduced
25
Closed
15
Top Buys
| 1 |
ETP
Energy Transfer Partners L.p.
ETP
|
$5.09M |
| 2 |
EEP
Enbridge Energy Partners
EEP
|
$3.39M |
| 3 |
WPZ
Williams Partners L.P.
WPZ
|
$3.33M |
| 4 |
Plains All American Pipeline
PAA
|
$3.25M |
| 5 |
OKS
Oneok Partners LP
OKS
|
$2.89M |
Top Sells
| 1 |
Targa Resources
TRGP
|
$615K |
| 2 |
XNPT
XENOPORT, INC.
XNPT
|
$458K |
| 3 |
Exelixis
EXEL
|
$314K |
| 4 |
MDVN
MEDIVATION, INC.
MDVN
|
$310K |
| 5 |
Theravance Biopharma
TBPH
|
$304K |
Sector Composition
| 1 | Energy | 64.18% |
| 2 | Healthcare | 25.09% |
| 3 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RLYP
51
DELISTED
RELYPSA INC COM
RLYP
| $521K | 0.39% |
28,163
+18,936
| +205% | +$350K |
|
|
MNTA
52
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $520K | 0.39% |
48,151
+10,869
| +29% | +$117K |
|
53
Regeneron Pharmaceuticals
REGN
$59.8B
| $519K | 0.39% |
1,485
+428
| +40% | +$150K |
|
54
Enanta Pharmaceuticals
ENTA
$189M
| $514K | 0.38% |
23,292
+4,603
| +25% | +$102K |
|
55
Nektar Therapeutics
NKTR
$543M
| $514K | 0.38% |
2,410
-141
| -6% | -$30.1K |
|
56
Omeros
OMER
$284M
| $514K | 0.38% |
48,887
+4,650
| +11% | +$48.9K |
|
57
Vertex Pharmaceuticals
VRTX
$102B
| $512K | 0.38% |
5,955
+922
| +18% | +$79.3K |
|
|
MDCO
58
DELISTED
Medicines Co
MDCO
| $502K | 0.37% |
14,919
-412
| -3% | -$13.9K |
|
|
PGNX
59
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $499K | 0.37% |
118,285
+14,478
| +14% | +$61.1K |
|
|
ARIA
60
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $489K | 0.36% |
66,113
-26,489
| -29% | -$196K |
|
|
ALXN
61
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $484K | 0.36% |
4,147
+980
| +31% | +$114K |
|
|
ARNA
62
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $475K | 0.35% |
27,761
-4,550
| -14% | -$77.9K |
|
|
MACK
63
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $472K | 0.35% |
11,118
+7,105
| +177% | +$302K |
|
64
Acadia Pharmaceuticals
ACAD
$4.34B
| $450K | 0.33% |
13,877
+6,520
| +89% | +$211K |
|
65
Cheniere Energy
CQP
$26B
| $350K | 0.26% |
+11,685
| New | +$350K |
|
66
Xencor
XNCR
$594M
| $335K | 0.25% |
17,649
-391
| -2% | -$7.42K |
|
67
Atara Biotherapeutics
ATRA
$88.7M
| $285K | 0.21% |
506
+49
| +11% | +$27.6K |
|
68
Cytokinetics
CYTK
$5.98B
| $279K | 0.21% |
29,379
+7,255
| +33% | +$68.9K |
|
|
LUMO
69
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
| $275K | 0.2% |
2,718
+1,937
| +248% | +$196K |
|
70
Novavax
NVAX
$1.2B
| $273K | 0.2% |
1,878
+339
| +22% | +$49.3K |
|
|
ONCE
71
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $270K | 0.2% |
5,281
+30
| +0.6% | +$1.53K |
|
|
BLUE
72
DELISTED
bluebird bio
BLUE
| $267K | 0.2% |
476
+148
| +45% | +$83K |
|
|
ARRY
73
DELISTED
Array Biopharma Inc
ARRY
| $267K | 0.2% |
75,100
+8,724
| +13% | +$31K |
|
74
Iovance Biotherapeutics
IOVA
$800M
| $265K | 0.2% |
32,726
+374
| +1% | +$3.03K |
|
|
BPMC
75
DELISTED
Blueprint Medicines
BPMC
| $264K | 0.2% |
13,046
+2,562
| +24% | +$51.8K |
|